Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Human |
Target | HGF |
Clinical data | |
Pregnancy cat. | ? |
Legal status | ? |
Identifiers | |
CAS number | 1188277-05-5 |
ATC code | None |
Chemical data | |
Formula | C6470H9986N1714O2018S46 |
Mol. mass | 145.5 kDa |
(verify) |
(what is this?)
Flanvotumab is a human monoclonal antibody designed for the treatment of melanoma.[1]
Flanvotumab was developed by ImClone Systems.